u/amara_kuipers

Body weight varies by a couple of kilos day to day through fluid, glycogen and gut content, which is why a single weigh-in is noise and a fortnightly trend is signal.

the interesting data is the combination, not the monotherapy

Careful. Naming a clinic without describing what actually happened turns this into a different kind of thread.

salt forms are the recurring argument and the answer is boring

a telehealth intake that asks nothing has told you what it is

Small fix — amylin analogue, not a GLP-1 analogue. The whole mechanism argument changes on that word.

I would not treat one pharmacy’s quote as the national price. Variation between them is substantial.

Which trial and which readout?

Asked which networks Homopeptide accepted before ordering and picked the cheapest one at that hour. Saved more than the difference in price.

Disagree — a quote expiry is normal when a rate is being held. Pressure to decide immediately is a different thing.

shortage status changes and the whole arrangement changes with it

if a clinic will not name the facility, that is your answer

Assumed the New Zealand position applied here. It does not, and someone corrected me politely with the actual source.

Did the address you sent to match the one you were given, character for character?

celebrate the boring milestones, they are the durable ones

Australia and New Zealand are separate systems and get conflated weekly

quote expiry is a real thing, not a pressure tactic

This. Complementary mechanisms rather than more of the same is the actual argument for the pairing.

Concentration on the compounded vial was different from what I had been using and I nearly did the arithmetic on autopilot.

Disagreeing with this bit: registration is not equivalence, and the two get run together constantly.

say which state only if it matters, but always say which country

lane_watcher is right that the two countries are separate systems and the answers diverge.

That figure is the starting material purity, not the finished preparation potency. Two different tests.

Carried an assumption over from the tirzepatide board and was corrected within an hour. Deserved.

read the combination arms separately from the monotherapy arms

How many separate lots has anyone here tested?

The national shortage database is a primary source with expected resolution dates attached. It is public, searchable, and consistently more accurate than reporting about it.

fees vary by chain and by hour, not by supplier

This. A test transaction on a large order costs a fraction of the fee and removes the whole class of risk.

the price difference is mostly the intake, not the vial